Portal Hypertension News

Overweight and obesity are significant risk factors for liver disease, especially fatty liver disease. Weight loss and exercise can not only decrease the risk for developing fatty liver but also improve outcomes after liver transplantation, protect and reverse hepatic steatosis, and improve kidney function in patients with nonalcoholic steatohepatitis.

WASHINGTON — Beginning Friday, October 20, Healio Gastroenterology and Liver Disease will provide live coverage from the The Liver Meeting 2017.

ORLANDO — Measuring hepatic pressure should be done by gastroenterologists and hepatologists because it can best direct treatment and outcomes, according to an international expert at the World Congress of Gastroenterology at ACG 2017.

CHICAGO — In this exclusive video from Digestive Disease Week, Norah Terrault, MD, MPH, discusses the topics reviewed during a press conference involving several experts attending the meeting. Some of the key features of the meeting included new developments for treating hepatitis C, new data emerging on difficult to treat groups such as persons who inject drugs, and the industry’s focus on fatty liver disease.

Researchers have identified a unique GI bleeding syndrome associated with cirrhosis and portal hypertension, which they call “acute on chronic GI bleeding.”

Recent findings suggest noninvasive tests can be used to identify patients with compensated liver disease at high risk for clinically significant portal hypertension and varices needing treatment.

The FDA granted BioVie Inc. orphan drug designation for BIV201 for the treatment of ascites in all instances except those caused by cancer, according to the company.

A combined model of non-invasive quantitative MRI measures of liver spine-echo echo planar imaging longitudinal relaxation time and splenic artery velocity can provide an estimation of portal pressure that is significantly correlated with hepatic venous pressure gradient measurement, according to recent findings published in the Journal of Hepatology.

At the All India Institute of Medical Sciences, new prognostic scores developed for hepatic venous outflow tract obstruction were superior to other scores, according to recent findings published in Alimentary Pharmacology and Therapeutics. Further, the researchers found child class and no response to intervention were associated with poor outcomes.

Transjugular intrahepatic portosystemic shunts were safe and effective in treating the complications of patients with idiopathic noncirrhotic portal hypertension who had normal kidney function and no severe extrahepatic conditions, according to recent findings published in Hepatology.